ARPA-H awards $125M for manufacturing custom RNA therapies on demand
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"ARPA-H awards $125M for manufacturing custom RNA therapies on demand" is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Harvard Medical School, The Pharma Letter, pharmaphorum and Newswise. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 74d ago.
Quick answers
Why is "ARPA-H awards $125M for manufacturing custom RNA therapies on demand" trending?
Because 7 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- ARPA-H Funds HMS-Led Pilot Project to Develop New Class of RNA Medicines Harvard Medical School · 77d ago
- ARPA-H backs five teams with $125m to make RNA meds on demand The Pharma Letter · 77d ago
- US puts $125m into personalised RNA therapy production pharmaphorum · 77d ago
- ARPA-H Funds HMS-Led Pilot Project To Develop New Class of RNA Medicines Newswise · 77d ago
- Waterfall Scientific Awarded $54.5 Mln To Lead Consortium For Cell-Free mRNA Manufacturing TradingView · 77d ago
- ARPA-H funds biotechs working on custom RNA therapies STAT · 77d ago
- ARPA-H awards $125M for manufacturing custom RNA therapies on demand Endpoints News · 77d ago
Topics
Related trends
Amyloid Fibers Have an Unexpected Role in Sperm, Scientists Discover
Scientists discover amyloid fibers — linked to Alzheimer's — play a vital role in delivering RNA to sperm and mouse embryos.
All 5 genetic “letters” of DNA and RNA discovered in a 4.5-billion-year-old asteroid
Scientists find all five genetic letters of DNA and RNA in a 4.5-billion-year-old asteroid, offering new clues on life's origins.
Urine cell-free RNA for bladder cancer detection and treatment response prediction
Recent studies show a simple urine test analyzing cell-free RNA can detect bladder cancer and track treatment.
A ribozyme ligase that requires a 3′ terminal phosphate on its RNA substrate
A protein‑free ribozyme ligase that seeks out and repairs broken RNA reshapes ideas about early life and genome maintenance.
Protein fibers, a hallmark of Alzheimer's, spotted making genetic deliveries to sperm cells
Amyloid protein fibers typically associated with Alzheimer's disease have been observed delivering genetic material to sperm cells.
Squid Are Even More Alien-Like Than We Thought, With an Unmatched Ability to Change Genetic Expression
5 news sources are covering this Science story right now — PULSE is tracking how fast it spreads.